Skip to main content

"To me, hope is informed optimism."

- Michael J. Fox

Scroll

United States Capitol building
The National Plan to End Parkinson’s Act Has Been Passed by Congress!

The U.S. Senate unanimously passed the National Plan to End Parkinson’s Act, the first-ever federal legislation dedicated to ending Parkinson’s disease, sending the bill to President Biden’s desk to be signed into law.

Our single, urgent goal: Eliminate Parkinson's disease in our lifetime.

Over $ 1 billion funded in research programs to date

Get Involved

You too can make a difference.

“Parkinson's patients are the experts on what we have. We have a responsibility as patients to share our experience — what works for us, what we respond to, what we can contribute to research.”

— Michael J. Fox

  • Researcher holding a tablet with brain scan.

    Donate to Research

    Your support will help usher in a future without Parkinson's disease.

    Donate now
  • Male and female couple smiling for the camera at a Tour de Fox cycling event.

    Fundraise for a Cure

    Thousands of Team Fox members worldwide are turning their passions and interests into millions in funding for Parkinson's research.

    Join an event
  • Person with glasses sitting down

    Be Part of the Answer

    You have the power to impact your future and the future of millions living with Parkinson's disease. Explore participating in clinical research today.

    Join a study
  • Two male advocates in front of the United States Capitol building at the Parkinson's Policy Forum.

    Public Policy Matters

    Your voice and your story can shape policymakers' decisions on issues of importance to the Parkinson's community.

    Take action today
/
Dan Kinel
“Participating in research changes how you view your diagnosis… and the world around you. It makes you feel like you are playing an important role in solving a problem that affects millions of people.”
— Dan Kinel, Rochester, NY
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.